SELLAS Life Sciences to Present Preclinical Data Highlighting Potent Activity of SLS009 in AML at the 2026 AACR Conference
Go back to SELLAS Life Sciences to Present Preclinical Data Highlighting Potent Activity of SLS009 in AML at the 2026 AACR Conference| RiverSource LaSalle Internatio (NASDAQ: SLS) | Delayed: 14.98 +1.71 (12.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.27 | 52 Week High | $10.16 | |||
| Open | $13.20 | 52 Week Low | $6.52 | |||
| Day High | $15.05 | P/E | N/A | |||
| Day Low | $12.95 | EPS | $0.00 | |||
| Volume | 17,275,570 | |||||
